LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
15,972,246
Share change
-185,789
Total reported value
$255,675,832
Put/Call ratio
89%
Price per share
$16.00
Number of holders
72
Value change
-$9,198,138
Number of buys
38
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2016

As of 30 Jun 2016, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,972,246 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, Broadfin Capital, LLC, JANUS CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LLC, FRANKLIN RESOURCES INC, Allianz Asset Management AG, VANGUARD GROUP INC, and BlackRock Fund Advisors. This page lists 72 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.